Brightspring Health Services (BTSG) closed at $62.84 on November 20, 2026, down 1.8% from the previous close, on volume of 3,132,486 shares (30-day average 2,328,606).
Data as of November 20, 2026.
20-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 20, 2026 | Diagonal Put Spread | 20-Nov : 18-Dec-2665 : 60 P | 1,500 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 20, 2026. See the largest for 5, 30, 60 and 90 days
BrightSpring Health Services, Inc. (BTSG) Receives a Buy from BMO Capital
TipRanks (Wed, 18-Nov 8:37 AM ET)
Market Chameleon (Fri, 30-Oct 6:23 AM ET)
BrightSpring (BTSG) raises full-year guidance after Q3 revenue climbs to $4,213 million
Market Chameleon (Fri, 30-Oct 3:36 AM ET)
Globe Newswire (Fri, 30-Oct 6:00 AM ET)
Globe Newswire (Thu, 1-Oct 8:05 AM ET)
Market Chameleon (Thu, 4-Jun 3:54 AM ET)
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Brightspring Health Services trades on the NASDAQ stock market under the symbol BTSG.
As of November 20, 2026, BTSG stock price declined to $62.84 with 3,132,486 million shares trading.
BTSG has a beta of 0.98, meaning it tends to be less sensitive to market movements. BTSG has a correlation of 0.15 to the broad based SPY ETF.
BTSG has a market cap of $12.50 billion. This is considered a Large Cap stock.
Last quarter Brightspring Health Services reported $4 billion in Revenue and $.54 earnings per share. This beat revenue expectation by $342 million and exceeded earnings estimates by $.07.
The top ETF exchange traded funds that BTSG belongs to (by Net Assets): IJH, IWM, VTI, VB, VBK.
BTSG has outperformed the market in the last year with a return of +91.8%, while the SPY ETF gained +6.9%. In the last 3 month period, BTSG beat the market returning +5.6%, while SPY returned -9.3%. However, in the most recent 2 weeks BTSG has underperformed the stock market by returning -6.4%, while SPY returned -6.2%.
BTSG support price is $61.92 and resistance is $66.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BTSG shares will trade within this expected range on the day.